Literature DB >> 11826613

Ligand-dependent and -independent processes in B-cell-receptor-mediated signaling.

E M Fuentes-Pananá1, J G Monroe.   

Abstract

The B cell antigen receptor (BCR) is a protein complex expressed on the surface of immature and mature B cells. After ligand-induced aggregation, this complex generates signals that lead to a variety of biological outcomes, including survival, proliferation and differentiation. During B cell development intermediate forms of the BCR are expressed on the surface. The composition of these pro- and preBCR complexes reflects the ordered assembly of the BCR complex and they exist to generate signals for positive selection at defined developmental checkpoints. Because these receptors lack the ability to bind conventional ligands, the pro- and preBCR have been postulated to signal via ligand-independent processes. This ligand-independent or constitutive signal may also play a role in the survival of peripheral mature B cells. Here we discuss the evidence for ligand-independent functions for the BCR and postulate how it may be regulated and linked to biological processes associated with B cell development and survival.

Mesh:

Substances:

Year:  2001        PMID: 11826613     DOI: 10.1007/s281-001-8163-6

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  73 in total

Review 1.  Adapters in lymphocyte signalling.

Authors:  A Leo; B Schraven
Journal:  Curr Opin Immunol       Date:  2001-06       Impact factor: 7.486

2.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1.

Authors:  D Woods; D Parry; H Cherwinski; E Bosch; E Lees; M McMahon
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Mutations within the NH2-terminal transmembrane domain of membrane immunoglobulin (Ig) M alters Ig alpha and Ig beta association and signal transduction.

Authors:  C H Michnoff; V S Parikh; D L Lelsz; P W Tucker
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

4.  CD3 components at the surface of pro-T cells can mediate pre-T cell development in vivo.

Authors:  H Jacobs; D Vandeputte; L Tolkamp; E de Vries; J Borst; A Berns
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

5.  Regulation of an early developmental checkpoint in the B cell pathway by Ig beta.

Authors:  S Gong; M C Nussenzweig
Journal:  Science       Date:  1996-04-19       Impact factor: 47.728

6.  Counterselection against D mu is mediated through immunoglobulin (Ig)alpha-Igbeta.

Authors:  S Gong; M Sanchez; M C Nussenzweig
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

7.  The sequence of the mu transmembrane segment determines the tissue specificity of the transport of immunoglobulin M to the cell surface.

Authors:  G T Williams; A R Venkitaraman; D J Gilmore; M S Neuberger
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

8.  Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis.

Authors:  G Bannish; E M Fuentes-Pananá; J C Cambier; W S Pear; J G Monroe
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

9.  Ordered rearrangement of immunoglobulin heavy chain variable region segments.

Authors:  F W Alt; G D Yancopoulos; T K Blackwell; C Wood; E Thomas; M Boss; R Coffman; N Rosenberg; S Tonegawa; D Baltimore
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

10.  The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver.

Authors:  Y S Li; K Hayakawa; R R Hardy
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  1 in total

1.  T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression.

Authors:  Jeroen P Roose; Maximilian Diehn; Michael G Tomlinson; Joseph Lin; Ash A Alizadeh; David Botstein; Patrick O Brown; Arthur Weiss
Journal:  PLoS Biol       Date:  2003-11-17       Impact factor: 8.029

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.